|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| A61K 31/7056 | (2006.01) | ||
| A61K 38/21 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 1087778 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99927804.7 |
| Date of filing the European patent application | 1999-05-29 | |
| (97) | Date of publication of the European application | 2001-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2005-10-26 |
| (46) | Date of publication of the claims translation | 2006-02-27 |
| (86) | Number | PCT/EP1999/003746 |
| Date | 1999-05-29 |
| (87) | Number | WO 1999/064016 |
| Date | 1999-12-16 |
| (30) | Number | Date | Country code |
| 98110433 | 1998-06-08 | EP |
| (72) |
ZAHM, Friederike, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | PEG-IFN-alfa ir ribavirino panaudojimas lėtinio hepatito C gydymui |
| USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C |
| Payment date | Validity (years) | Amount | |
| 2018-05-21 | 20 | 347.00 EUR |